Female Sexual Dysfunction: Is It a Treatable Disease?

Area of Science:

• Reproductive Medicine
• Pharmacology
• Women's Health

Background:

• Female sexual dysfunction (FSD) affects approximately 40% of women.
• Its multi-factorial etiology necessitates diverse treatment approaches.
• No single treatment addresses the entirety of FSD.

Purpose of the Study:

• To provide an overview of recent research on treatments for female sexual dysfunction.
• To highlight novel therapeutic agents and approaches for FSD.

Main Methods:

• Literature review of recent research on FSD treatments.
• Discussion of pharmacological agents, mechanical devices, and hormonal therapies.

Main Results:

• Recent advancements offer new options for managing FSD symptoms.
• Novel agents like flibanserin show promise.
• Targeted hormonal treatments and mechanical devices address specific FSD subtypes.

Conclusions:

• Significant progress has been made in treating FSD symptoms.
• A range of treatments are available for specific FSD subtypes.
• Further research continues to expand therapeutic options for women's sexual health.